📰 Psychedelics News
Curated updates on microdosing, research, policy, and community.
Filters
Psychedelics excite cells in hippocampus to reduce anxiety
A classic psychedelic, similar to LSD, psilocybin and mescalin, was found to activate a cell type in the brain that silences other neighboring neurons, a result that provides insight into how such drugs reduce anxiety...
When serotonin dims the light
Signals in our brain are not always processed in the same way: certain receptors modulate these mechanisms, influencing our mood, perception, and behavior in various ways. One of these is the 5-HT2A receptor, which ha...
Study explores access to psychedelics for therapeutic use
Feeling safe and comfortable are key when discussing your health and wellbeing with your primary care provider. However, that feeling of comfort and safety can't be taken for granted among many people who have turned ...
'Out-of-body' research could lead to new ways to promote social harmony
Out-of-body experiences, such as near-death experiences, can have a 'transformative' effect on people's ability to experience empathy and connect with others, new research explains.
Advertise your Clinical Trials, Study or Survey with us
Are you a researcher looking to promote your psychedelic-related trials or studies? The Australian Psychedelic Society is here to help! We welcome you to share your research opportunities with our community. To have...
Study explains why laws are written in an incomprehensible style
A new study on 'legalese' suggests this convoluted language acts to convey a sense of authority in legal documents. The researchers also found that even non-lawyers use legalese when asked to write laws.
What's next?! BC2025
...and details of other European conferences in 2024
New method tracks how psychedelics affect neurons in minutes
A new tool to track the neurons and molecules activated in the brain by psychedlic drugs could help scientists unlock the benefits of psychedelic treatments for patients with brain disorders.
Study: OCD symptoms and hallucinogenic drugs.
Research Project Title: Exploring the impact of hallucinogenic drugs on OCD related symptoms. Chief Investigator: Dr Vince Polito Associate Investigators: Professor Melissa Norberg, Dr Christina Perry, Ms Dora Szabo
Women’s Health and Psychedelics – New Insights
Using validated behavior models and known standards, studies are finding significant differences between male and female rodents given psychedelic drugs.
Psilocybin generates psychedelic experience by disrupting brain network
Researchers report that psilocybin, the active ingredient in magic mushrooms, destabilizes a critical network of brain areas involved in introspective thinking. The findings provide a neurobiological explanation for t...
Psymposia’s Response to Heroic Hearts’ Pharma-Backed Press Conference
Veterans deserve the highest quality treatment for PTSD. It’s unacceptable and dangerous to use veterans as guinea pigs for a big pharma profit grab without resolving safety and efficacy concerns. The post Psymposia’...
Two new species of Psilocybe mushrooms discovered in southern Africa
In a new paper, researchers and citizen mycologists describe the two new species as Psilocybe ingeli and Psilocybe maluti. The paper also contains information on the traditional use of P. maluti by Basotho traditional...
Ketamine slow-release tablet reduces symptoms of severe depression: Clinical trial
A slow-release, tablet form of ketamine with minimal side-effects has the potential to make treatment more affordable and accessible.
Can LSD confer psychological strength and resilience?
Lifetime LSD use is associated with a higher likelihood of severe psychological distress after losing one's job, according to a new study.